Skip to main content

Advertisement

Log in

The curious case of clioquinol

  • News Feature
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A Corrigendum to this article was published on 01 May 2009

This article has been updated

An indigestion drug blamed for a debilitating illness that affected thousands of people in the 1950s has been resurrected as a potential treatment for Alzheimer's disease. But not everyone is cheering for the drug, clioquinol, to make a comeback. Lauren Cahoon reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Change history

  • 07 May 2009

    In the version of this article initially published, Ashley Bush of the Mental Health Research Institute in Melbourne, Australia is cited as the sole originator of the metals theory for Alzheimer’s disease, and Prana Biotechnology is described as being founded in Melbourne. The theory and Prana Biotechnology were jointly developed by Bush and Rudolph Tanzi of Massachusetts General Hospital, with the help of Rob Moir, and in collaboration with Colin Masters of the University of Melbourne. Additionally, it was Michel Xilinas who recognized the chelating properties of clioquinol. The errors have been corrected in the HTML and PDF versions of the article.

References

  1. Schaumburg, H. Experimental and Clinical Neurotoxicology (ed. Spencer, P.) Ch. 27, 395–406 (Oxford University Press, New York, 2000).

    Google Scholar 

  2. Cherny, R.A. et al. Neuron 30, 665–676 (2001).

    Article  CAS  Google Scholar 

  3. Ritchie, C.W. Arch. Neurol. 60, 1685–1691 (2003).

    Article  Google Scholar 

  4. Nakae, K., Yamamoto, S., Shigematsu, I. & Kono R. Lancet 301, 171–173 (1973).

    Article  Google Scholar 

  5. Shigematsu, I., Yanagawa, H., Yamamoto, S. & Nakae, K. Jpn. J. Med. Sci. Biol. 28, 23–33 (1975).

    Article  Google Scholar 

  6. Lannfelt, L. et al. Lancet Neurol. 7, 779–786 (2008).

    Article  CAS  Google Scholar 

  7. Nguyen, T., Hamby, A. & Massa, S.M. Proc. Natl. Acad. Sci. 102, 11840–11845 (2005).

    Article  CAS  Google Scholar 

  8. Kaur, D. et al. Neuron 37, 899–909 (2003).

    Article  CAS  Google Scholar 

  9. Wang, Y. et al. J. Biol. Chem. 284, 314–323 (2009).

    Article  CAS  Google Scholar 

  10. Ding, W.Q. et al. Cancer Res. 65, 3389–3395 (2005).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cahoon, L. The curious case of clioquinol. Nat Med 15, 356–359 (2009). https://doi.org/10.1038/nm0409-356

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0409-356

  • Springer Nature America, Inc.

This article is cited by

Navigation